Christopher Galloway
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Pneumonia and Respiratory Infections, Antibiotic Resistance in Bacteria, Hepatitis C virus research, Dialysis and Renal Disease Management
Most-Cited Works
- → Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment(2016)101 cited
- → Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial(2024)43 cited
- → Liver Transplantation for Severe Alcoholic Hepatitis: Report of a Single Center Pilot Program(2018)13 cited
- → FP658JTZ-951, A NOVEL HIF-PHD INHIBITOR, DEMONSTRATES INCREASES IN HEMOGLOBIN, IRON MOBILIZATION, REPRODUCIBLE PHARMACOKINETICS, AND SAFETY FOLLOWING ONCE DAILY ADMINISTRATION FOR 15 DAYS IN PATIENTS WITH ANEMIA RECEIVING HEMODIALYSIS(2015)7 cited
- → Trans Sodium Crocetinate (TSC) to Improve Oxygenation in COVID-19(2021)3 cited
- → Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ‐56914845 (GSK2336805) in subjects with hepatic impairment(2015)2 cited
- → Hepatitis A Viral Safety of Plasma‐Derived Factor VIII Concentrate Koate®‐HP(1994)2 cited